Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
xiang bei yangrong tang (1 trial)
Breast Neoplasms (Phase 2)
Cognitive Dysfunction (Phase 2)
Fatigue (Phase 2)
Trials (1 total)
Trial APIs (1 total)